Craftroot Retail Limited has received board approval to raise Rs 22 crore through the issuance of 2 crore convertible warrants at Rs 11 each. The fundraising includes allocation to both promoters and public investors. The company is also increasing its authorized share capital to Rs 23.50 crore to support this process. Shareholders will vote on these resolutions at the upcoming EGM on November 5, 2026. This move strengthens the company's liquidity, though investors should note the potential future equity dilution upon warrant conversion.
Craftroot Retail Announces Rs 22 Crore Preferential Issue
The company is issuing 2,00,00,000 warrants at Rs 11 each.
Authorised share capital will rise from Rs 3.50 crore to Rs 23.50 crore.
Reader Takeaway: Fund infusion improves liquidity, but investors should monitor future EPS dilution as warrants are exercised over 18 months.
What just happened
Craftroot Retail Limited has announced a capital infusion plan totaling Rs 22 crore. The company board approved the issuance of 2 crore convertible warrants on a preferential basis. These warrants are priced at Rs 11 per unit, adhering to SEBI (ICDR) Regulations. Subscribers are required to pay a 25% upfront amount, with the remaining 75% due upon exercise within an 18-month window. The company is also increasing its authorized share capital from Rs 3.50 crore to Rs 23.50 crore to accommodate the potential share expansion.
Why this matters
This fundraising provides Craftroot Retail with immediate capital to support its operations and growth requirements. The participation of both promoter-linked entities—such as Anar Patel and Seher Retail—and public entities indicates a concerted effort to stabilize and strengthen the company's balance sheet. However, the conversion of these warrants into equity will increase the total outstanding share count, which will mathematically impact the Earnings Per Share (EPS) for current shareholders once the conversion occurs.
What changes now
The company has scheduled an Extra-Ordinary General Meeting (EGM) for November 5, 2026. Shareholders will need to vote on the authorization of the capital increase and the preferential allotment. Rupal Patel has been appointed to scrutinize the e-voting process to ensure regulatory compliance.
Risks to watch
The primary risk for retail investors is the dilution of their holding percentage once the warrants are converted into equity shares. Additionally, if the warrants are not exercised within the 18-month tenure, they will lapse and the upfront 25% payment will be forfeited, potentially signaling a loss of momentum for the intended capital expansion strategy.
What to track next
Investors should track the outcome of the November 5 EGM. Following shareholder approval, monitoring the actual allotment and the subsequent timeline for warrant exercise will be critical to understanding the company's long-term capital structure.